Compare AFYA & PURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AFYA | PURR |
|---|---|---|
| Founded | 1999 | 2025 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.0B |
| IPO Year | 2019 | N/A |
| Metric | AFYA | PURR |
|---|---|---|
| Price | $14.07 | $9.22 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $17.00 | $8.15 |
| AVG Volume (30 Days) | 83.5K | ★ 18.9M |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.90% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.43 | N/A |
| Revenue Next Year | $7.15 | $148.78 |
| P/E Ratio | $9.30 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.00 | $3.01 |
| 52 Week High | $18.16 | $11.73 |
| Indicator | AFYA | PURR |
|---|---|---|
| Relative Strength Index (RSI) | 46.73 | 55.52 |
| Support Level | $13.94 | $5.27 |
| Resistance Level | $14.77 | $11.73 |
| Average True Range (ATR) | 0.48 | 0.87 |
| MACD | -0.04 | -0.04 |
| Stochastic Oscillator | 46.27 | 42.00 |
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergraduate, deriving key revenue provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.
Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. HSI aims to provide capital-efficient and productive access to the HYPE token for U.S. and institutional investors, generating compounding shareholder returns that individual holders may not be able to replicate through staking, yield optimization, and active ecosystem engagement. HSI is positioned to become the largest HYPE-focused digital asset treasury vehicle capitalizing on Hyperliquid's rapid growth and providing exposure to one of the largest and fastest growing revenue pools in digital assets.